i3 Health

i3 Health i3 Health is a jointly accredited provider of CME/NCPD/CPE for the interprofessional healthcare team

i3 Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. i3 Health is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's (ANCC) Commission on Accreditation. i3 Health is accredited as a provider of continuing nursing education by the California Board of Registered Nursing (CBRN).

Your Update: Here’s what’s new this week from i3 Health!Addressing Fear of Recurrence in Breast Cancer Survivorship Ca...
10/29/2025

Your Update: Here’s what’s new this week from i3 Health!

Addressing Fear of Recurrence in Breast Cancer Survivorship Care With Armaan Jamal: https://bit.ly/3JvEjHU

Improving Oncologic and Genetic Management of Von Hippel-Lindau Disease: https://bit.ly/3WstEkk

Beyond MARS 2: Perspectives on Surgery in Pleural Mesothelioma With Jeffrey Velotta, MD: https://bit.ly/3LvO8WO

October is Eczema Awareness Month. Atopic dermatitis affects up to 20% of U.S. children and carries a high symptom burde...
10/28/2025

October is Eczema Awareness Month. Atopic dermatitis affects up to 20% of U.S. children and carries a high symptom burden—pruritus, pain, and sleep disturbance—driving significant quality-of-life impact for families.

Learn more in our atopic dermatitis course led by Peter A. Lio, MD, and Linda F. Stein Gold, MD: https://bit.ly/40dd3nc

There are now 9 actionable genomic targets in lung cancer, including HER2, enabling more personalized therapy and improv...
10/28/2025

There are now 9 actionable genomic targets in lung cancer, including HER2, enabling more personalized therapy and improved outcomes.

Learn more here: bit.ly/3DgE144

Julia Kathleen Rotow, MD | Dana-Farber Cancer Institute; Harvard Medical School

10/27/2025

Up to 50% of biliary tract cancer cases have targetable molecular alterations, making comprehensive biomarker testing essential for personalized treatment.

Explore the latest insights: https://www.youtube.com/watch?v=ZuJpHcqi7dY

Dr. Rachna Shroff | University of Arizona Cancer Center
Dr. Anjana Pillai | University of Chicago Medicine Comprehensive Cancer Center

Extrapulmonary neuroendocrine carcinomas account for only 9% of all NECs, with one-third originating in the gastrointest...
10/27/2025

Extrapulmonary neuroendocrine carcinomas account for only 9% of all NECs, with one-third originating in the gastrointestinal tract. Early and accurate diagnosis is critical to improving outcomes.

Start the activity here: bit.ly/3JVe79s

Dr. Andrew E. Hendifar | Cedars-Sinai Medical Center

Elevate your expertise with i3 Health’s accredited activities!Access expertly designed courses that provide cutting-edge...
10/26/2025

Elevate your expertise with i3 Health’s accredited activities!

Access expertly designed courses that provide cutting-edge insights, evidence-based strategies, and valuable CME/NCPD credits. Take your practice to the next level with i3 Health.

Explore now!

AI co-scientists are moving from concept to clinic—multi-agent systems that generate, rank, and stress-test hypotheses a...
10/25/2025

AI co-scientists are moving from concept to clinic—multi-agent systems that generate, rank, and stress-test hypotheses are speeding discovery, sharpening imaging and biomarker questions, and narrowing drug-repurposing targets.

See what Google’s “hypothesis tournaments” reveal, what’s launching across the ecosystem, and a pragmatic path from in silico ideas to real-world validation.

Learn more here: https://bit.ly/4ot8cHG

Join Archie Franklin, MBA, for an activity on screening for early psoriatic arthritis and tailoring therapy by disease s...
10/24/2025

Join Archie Franklin, MBA, for an activity on screening for early psoriatic arthritis and tailoring therapy by disease severity, comorbidities, and patient preference.

Mr. Franklin is a plaque psoriasis patient and longtime NPF volunteer (since 1989), serving as a Research Ambassador, Honored Patient Speaker, Chair of the Indianapolis Walk to Cure Psoriasis, and participant in Capitol Hill Day. He also consults part-time within the pharmaceutical industry as a patient-focused ambassador and educator at dermatology events.

Learn more here: https://bit.ly/4hGLHuX

"Systemic mastocytosis is often misdiagnosed due to its nonspecific symptoms. Early detection is critical to reduce symp...
10/23/2025

"Systemic mastocytosis is often misdiagnosed due to its nonspecific symptoms. Early detection is critical to reduce symptom burden and improve outcomes." – Dr. Mariana Castells, Harvard Medical School

Claim 0.5 CME/NCPD/AAPA credits now: https://bit.ly/4jdGf4A

Lobular breast cancer is finally getting the spotlight it deserves—awareness is rising, imaging is improving, and dedica...
10/23/2025

Lobular breast cancer is finally getting the spotlight it deserves—awareness is rising, imaging is improving, and dedicated trials are opening for patients, including the first US study for metastatic lobular disease.

Watch the interview: bit.ly/3Wgqlwt

Jason Mouabbi, MD | MD Anderson Cancer Center

Are you ready to improve early diagnosis and management of psoriatic arthritis?Learn from our expert panel as they discu...
10/22/2025

Are you ready to improve early diagnosis and management of psoriatic arthritis?

Learn from our expert panel as they discuss strategies for early intervention and treatment.

Claim 1.25 CME/NCPD/CPE credits now: https://bit.ly/4hGLHuX

Your Update: Here’s what’s new this week from i3 Health!Beyond the Pink: Turning Breast Cancer Awareness to Action: bi...
10/22/2025

Your Update: Here’s what’s new this week from i3 Health!

Beyond the Pink: Turning Breast Cancer Awareness to Action: bit.ly/48GSILJ

Additional Advances in Systemic Mastocytosis Research and Clinical Trials With Mariana Castells, MD, PhD: bit.ly/3KUKBRX

Cemiplimab Approved for Adjuvant Treatment of High-Risk CSCC: bit.ly/475wJgh

Address

365 West Passaic Street
Rochelle Park, NJ
07662

Opening Hours

Monday 8am - 4pm
Tuesday 8am - 4pm
Wednesday 8am - 4pm
Thursday 8am - 4pm
Friday 8am - 4pm

Website

Alerts

Be the first to know and let us send you an email when i3 Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

i3 Health is an accredited provider CME/NCPD for the multidisciplinary cancer care team. Earn AMA PRA Category 1 Credit™, contact hours, MOC points, pharmacotherapy credit, and ILNA points from the comfort of your home or office. Best of all, it’s completely FREE!